Get the Stockscreener App
33.78
1.20%
0.40
Synaptogenix Inc stock is traded at $33.78, with a volume of 13,383.
It is up +1.20% in the last 24 hours and up +330.32% over the past month.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
See More
Previous Close:
$33.38
Open:
$33.69
24h Volume:
13,383
Relative Volume:
0.02
Market Cap:
$7.07M
Revenue:
-
Net Income/Loss:
$-8.22M
P/E Ratio:
-4.5367
EPS:
-7.4459
Net Cash Flow:
$-4.78M
1W Performance:
+23.69%
1M Performance:
+330.32%
6M Performance:
+1,156%
1Y Performance:
+1,041%
1-Day Range:
$33.60
$34.44
1-Week Range:
$28.85
$34.44
52-Week Range:
$1.84
$34.44
Synaptogenix Inc Stock (SNPX) Company Profile
Name
Synaptogenix Inc
Sector
Industry
Phone
(973) 242-0005
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Compare SNPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNPX
Synaptogenix Inc
|
33.78 | 7.07M | 0 | -8.22M | -4.78M | -7.4459 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Synaptogenix Inc Stock (SNPX) Latest News
Value Recap: Does Synaptogenix Inc stock trade at a discount to peers2025 Earnings Surprises & Community Trade Idea Sharing - BỘ NỘI VỤ
How strong is Synaptogenix Inc. stock balance sheetTreasury Yields & Community Consensus Trade Signals - Newser
Will Synaptogenix Inc. stock reach all time highs in 2025Earnings Overview Report & Low Drawdown Trading Techniques - Newser
Does Synaptogenix Inc. stock trade at a discount to peersBreakout Watch & Capital Efficient Trade Techniques - Newser
Head to Head Comparison: Synaptogenix (NASDAQ:TAOX) versus Ceapro (OTCMKTS:CRPOF) - Defense World
Why hedge funds are buying Synaptogenix Inc. stockRisk Management & Weekly Setup with High ROI Potential - newser.com
Using R and stats models for Synaptogenix Inc. forecastingMarket Risk Report & Verified Short-Term Plans - newser.com
Is Synaptogenix Inc. stock a dividend growth opportunityM&A Rumor & Safe Entry Point Identification - newser.com
Will Synaptogenix Inc. stock outperform tech sector in 2025July 2025 Technicals & Fast Moving Stock Watchlists - newser.com
How rising interest rates impact Synaptogenix Inc. stockJobs Report & Accurate Technical Buy Alerts - newser.com
Why Synaptogenix Inc. is moving todayProduct Launch & High Win Rate Trade Alerts - newser.com
Is Synaptogenix Inc. stock a bargain at current levelsLayoff News & Smart Investment Allocation Insights - newser.com
How to build a dashboard for Synaptogenix Inc. stockJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - newser.com
How moving averages guide Synaptogenix Inc. tradingJuly 2025 PostEarnings & Daily Price Action Insights - newser.com
Is GSPY stock ideal for retirement investorsJuly 2025 Retail & AI Enhanced Trading Signals - Fundação Cultural do Pará
[10-Q] TAO Synergies Inc. Quarterly Earnings Report | TAOX SEC FilingForm 10-Q - Stock Titan
How to build a custom watchlist for Synaptogenix Inc.CPI Data & Accurate Technical Buy Alerts - newser.com
Synaptogenix Inc. stock volume spike explainedJuly 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com
Can Synaptogenix Inc. stock reach $100 price target2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Synaptogenix Inc Stock (SNPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):